Marta Peñas-Prado

2.6k total citations
68 papers, 861 citations indexed

About

Marta Peñas-Prado is a scholar working on Genetics, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Marta Peñas-Prado has authored 68 papers receiving a total of 861 indexed citations (citations by other indexed papers that have themselves been cited), including 59 papers in Genetics, 32 papers in Pulmonary and Respiratory Medicine and 15 papers in Oncology. Recurrent topics in Marta Peñas-Prado's work include Glioma Diagnosis and Treatment (59 papers), Brain Metastases and Treatment (26 papers) and Neuroblastoma Research and Treatments (10 papers). Marta Peñas-Prado is often cited by papers focused on Glioma Diagnosis and Treatment (59 papers), Brain Metastases and Treatment (26 papers) and Neuroblastoma Research and Treatments (10 papers). Marta Peñas-Prado collaborates with scholars based in United States, Canada and Australia. Marta Peñas-Prado's co-authors include Mark R. Gilbert, Nazanin Majd, Terri S. Armstrong, Erik P. Sulman, Minesh P. Mehta, John de Groot, Barbara O’Brien, W.K. Alfred Yung, Jill S. Barnholtz‐Sloan and Mitchell Machtay and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer.

In The Last Decade

Marta Peñas-Prado

63 papers receiving 854 citations

Peers

Marta Peñas-Prado

GENET

PRM

RNMI

M. Lahutte France

Katharina Seystahl Switzerland

Ugonma Chukwueke United States

Luisa Bellu Italy

Ichiyo Shibahara Japan

Yong Cui China

Haihui Jiang China

Xiaoguang Qiu China

Mario Caccese Italy

M. Lahutte France

Marta Peñas-Prado

483 ×0.8

GENET

224 ×0.8

PRM

339 ×1.5

196 ×1.1

174 ×1.2

RNMI

Citations per year, relative to Marta Peñas-Prado Marta Peñas-Prado (= 1×) peers M. Lahutte

Countries citing papers authored by Marta Peñas-Prado

Since Specialization

Citations

This map shows the geographic impact of Marta Peñas-Prado's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marta Peñas-Prado with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marta Peñas-Prado more than expected).

Fields of papers citing papers by Marta Peñas-Prado

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marta Peñas-Prado. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marta Peñas-Prado. The network helps show where Marta Peñas-Prado may publish in the future.

Co-authorship network of co-authors of Marta Peñas-Prado

This figure shows the co-authorship network connecting the top 25 collaborators of Marta Peñas-Prado. A scholar is included among the top collaborators of Marta Peñas-Prado based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marta Peñas-Prado. Marta Peñas-Prado is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Price, Mackenzie, Corey Neff, Carol Kruchko, et al.. (2024). CBTRUS Statistical Report: American Brain Tumor Association & NCI Neuro-Oncology Branch Adolescent and Young Adult Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2016–2020. Neuro-Oncology. 26(Supplement_3). iii1–iii53. 29 indexed citations

Horbinski, Craig, et al.. (2024). Immunotherapy for Solitary Fibrous Tumor (Hemangiopericytoma). The Neurologist. 29(4). 250–253. 1 indexed citations

Price, Mackenzie, Corey Neff, Carol Kruchko, et al.. (2023). Capturing evolving definitions of 12 select rare CNS tumors: a timely report from CBTRUS and NCI-CONNECT. Journal of Neuro-Oncology. 165(2). 279–290. 2 indexed citations

Pratt, Drew, Marta Peñas-Prado, & Mark R. Gilbert. (2023). Clinical impact of molecular profiling in rare brain tumors. Current Opinion in Neurology. 36(6). 579–586.

Robertson, Ian, et al.. (2022). Recent Therapeutic Advances in Pituitary Carcinoma. SHILAP Revista de lepidopterología. 6(2). 74–83. 7 indexed citations

Peñas-Prado, Marta, et al.. (2021). Neoplastic meningitis in solid tumours: updated review of diagnosis, prognosis, therapeutic management, and future directions. Neurología (English Edition). 37(9). 794–805. 6 indexed citations

Weathers, Shiao‐Pei, Carlos Kamiya-Matsuoka, Rebecca A. Harrison, et al.. (2020). Phase I/II study to evaluate the safety and clinical efficacy of atezolizumab (atezo; aPDL1) in combination with temozolomide (TMZ) and radiation in patients with newly diagnosed glioblastoma (GBM).. Journal of Clinical Oncology. 38(15_suppl). 2511–2511. 14 indexed citations

Majd, Nazanin, Gregory N. Fuller, Jason T. Huse, et al.. (2019). RBM10 truncation in astroblastoma in a patient with history of mandibular ameloblastoma: A case report. Cancer Genetics. 231-232. 41–45. 4 indexed citations

Harrison, Rebecca A., Mark D. Anderson, David Cachia, et al.. (2019). Clinical trial participation of patients with glioblastoma at The University of Texas MD Anderson Cancer Center. European Journal of Cancer. 112. 83–93. 14 indexed citations

10.

Majd, Nazanin & Marta Peñas-Prado. (2019). Updates on Management of Adult Medulloblastoma. Current Treatment Options in Oncology. 20(8). 64–64. 43 indexed citations

11.

Peñas-Prado, Marta, Terri S. Armstrong, & Mark R. Gilbert. (2019). Progress in rare central nervous system tumors. Current Opinion in Neurology. 32(6). 895–906. 3 indexed citations

12.

Ali, Arif N., Peixin Zhang, W.K. Alfred Yung, et al.. (2018). NRG oncology RTOG 9006: a phase III randomized trial of hyperfractionated radiotherapy (RT) and BCNU versus standard RT and BCNU for malignant glioma patients. Journal of Neuro-Oncology. 137(1). 39–47. 25 indexed citations

13.

Yeboa, D.N., James B. Yu, Eric Liao, et al.. (2018). Differences in patterns of care and outcomes between grade II and grade III molecularly defined 1p19q co-deleted gliomas. Clinical and Translational Radiation Oncology. 15. 46–52. 10 indexed citations

14.

Hashimoto, Yuuri, Marta Peñas-Prado, Shouhao Zhou, et al.. (2018). Rethinking medulloblastoma from a targeted therapeutics perspective. Journal of Neuro-Oncology. 139(3). 713–720. 18 indexed citations

15.

Gittleman, Haley, Michael W. Kattan, Arnab Chakravarti, et al.. (2016). An independently validated nomogram for individualized estimation of survival among patients with newly diagnosed glioblastoma: NRG Oncology RTOG 0525 and 0825. Neuro-Oncology. 19(5). now208–now208. 131 indexed citations

16.

Lassman, Andrew B., Martin J. van den Bent, Hui Gan, et al.. (2016). Efficacy of a novel antibody-drug conjugate (ADC), ABT-414, with temozolomide (TMZ) in recurrent glioblastoma (rGBM). Annals of Oncology. 27. vi103–vi103. 2 indexed citations

17.

Gilbert, Mark R., Stephanie L. Pugh, Ken Aldape, et al.. (2016). NRG oncology RTOG 0625: a randomized phase II trial of bevacizumab with either irinotecan or dose-dense temozolomide in recurrent glioblastoma. Journal of Neuro-Oncology. 131(1). 193–199. 48 indexed citations

18.

Allen, Pamela K., Paul D. Brown, Soumen Khatua, et al.. (2014). Clinical Outcomes and Patterns of Failure in Pineoblastoma: A 30-Year, Single-Institution Retrospective Review. World Neurosurgery. 82(6). 1232–1241. 28 indexed citations

19.

Cachia, David, Khalida Wani, Marta Peñas-Prado, et al.. (2014). C11orf95–RELA fusion present in a primary supratentorial ependymoma and recurrent sarcoma. Brain Tumor Pathology. 32(2). 105–111. 15 indexed citations

20.

Peñas-Prado, Marta & Mark R. Gilbert. (2007). Molecularly targeted therapies for malignant gliomas: advances and challenges. Expert Review of Anticancer Therapy. 7(5). 641–661. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact